Search

Your search keyword '"Treprostinil -- Forecasts and trends -- Reports"' showing total 21 results
Start Over Descriptor "Treprostinil -- Forecasts and trends -- Reports" Topic pharmaceutical industry -- forecasts and trends
21 results on '"Treprostinil -- Forecasts and trends -- Reports"'

1. PH-ILD Market Analysis 2032 Unveils Breakthrough Therapies and Regulatory Milestones from DelveInsight, Featuring Leading Innovators Insmed Incorporated, Bellerophon Therapeutics, United Therapeutics

Subjects
Insmed Inc. -- Forecasts and trends, Long-distance telephone service -- Forecasts and trends -- Reports, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Long-distance telephone service, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-February 16, 2024-: PH-ILD Market Analysis 2032 Unveils Breakthrough Therapies and Regulatory Milestones from DelveInsight, Featuring Leading Innovators Insmed Incorporated, Bellerophon Therapeutics, United Therapeutics, (C)1994-2024 M2 COMMUNICATIONS RDATE:15022024 DelveInsight's [...]

Published
2024

2. Progressive Fibrosing Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight |Boehringer Ingelheim, FibroGen

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Medical research -- Forecasts and trends -- Reports, Medicine, Experimental -- Forecasts and trends -- Reports, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-February 14, 2024-: Progressive Fibrosing Interstitial Lung Disease Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight |Boehringer Ingelheim, FibroGen (C)1994-2024 M2 COMMUNICATIONS RDATE:13022024 [...]

Published
2024

3. Pulmonary Arterial Hypertension Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Sharp & Dohme, Janssen Pharma, Actelion, Gossamer Bio

Subjects
Merck & Company Inc. -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 18, 2023-: Pulmonary Arterial Hypertension Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Sharp & Dohme, Janssen Pharma, Actelion, Gossamer Bio (C)1994-2023 [...]

Published
2023

4. Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players - Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences

Subjects
Kyorin Pharmaceutical Company Ltd. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, United Therapeutics Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Sarcoidosis Market Insights report includes a comprehensive understanding of current treatment practices, sarcoidosis emerging drugs, market share [...]

Published
2023

5. Pulmonary Hypertension Associated with Interstitial Lung Disease Market Size in the 7MM was approx. USD 1200 Million in 2022, estimates DelveInsight

Subjects
Insmed Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, Respiratory agents -- Reports -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 22, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease Market Size in the 7MM was approx. USD 1200 Million in 2022, estimates DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:21092023 The [...]

Published
2023

6. Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio

Subjects
United Therapeutics Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Acceleron Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Hypertension -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging drugs, market share [...]

Published
2023

7. Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio

Subjects
United Therapeutics Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Acceleron Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Hypertension -- Forecasts and trends -- Reports, Market trend/market analysis, Business, News, opinion and commentary
Abstract

According to DelveInsight, the hypertension market in the 7MM is expected to significantly change during the study period 2019--2032. While the hypertension market has generally shown a positive trend, certain [...]

Published
2023

8. Pulmonary Sarcoidosis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Eilly Lilly, Novartis, aTyr Pharma, Inc., Kinevant Sciences GmbH

Subjects
Novartis Pharma AG -- Forecasts and trends, Business -- Research, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 27, 2023-: Pulmonary Sarcoidosis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Eilly Lilly, Novartis, aTyr Pharma, Inc., Kinevant Sciences GmbH (C)1994-2023 [...]

Published
2023

9. Pulmonary Hypertension Associated with Interstitial Lung Disease Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight

Subjects
Insmed Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 26, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:26062023 DelveInsight's 'Pulmonary [...]

Published
2023

10. Pulmonary Arterial Hypertension Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Inc., United Therapeutics, United Therapeutics, Aerovate

Subjects
Merck & Company Inc. -- Forecasts and trends, Business -- Research, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epoprostenol -- Reports -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 13, 2023-: Pulmonary Arterial Hypertension Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Inc., United Therapeutics, United Therapeutics, Aerovate (C)1994-2023 M2 COMMUNICATIONS [...]

Published
2023

11. Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Nitto Denko Corp. -- Forecasts and trends, Business -- Research, Respiratory agents -- Reports -- Forecasts and trends, Pulmonary fibrosis -- Reports -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Clinical trials -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's 'Idiopathic Pulmonary Fibrosis Pipeline Insight - 2023' report provides comprehensive global coverage of pipeline idiopathic pulmonary fibrosis [...]

Published
2023

12. Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Nitto Denko Corp. -- Forecasts and trends, Business -- Research, Respiratory agents -- Reports -- Forecasts and trends, Pulmonary fibrosis -- Reports -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Clinical trials -- Forecasts and trends -- Reports, Industrial research -- Germany -- United States -- United Kingdom -- Japan, Pharmaceutical industry -- Forecasts and trends, Research and development, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The prevalence of idiopathic pulmonary fibrosis has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of idiopathic pulmonary fibrosis and [...]

Published
2023

13. Interstitial Lung Diseases Pipeline Insight | Key Companies - Roche, Bayer, Insmed, Avalyn Pharma, PureTech Health, Novartis, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics, and Others

Subjects
Bayer AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Novartis AG -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 24, 2023-: Interstitial Lung Diseases Pipeline Insight | Key Companies - Roche, Bayer, Insmed, Avalyn Pharma, PureTech Health, Novartis, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics, and Others (C)1994-2023 [...]

Published
2023

14. Interstitial Lung Disease Pipeline Assets Segmented by Stage, Product Type, Route of Administration and Molecule Type

Subjects
United States. Food and Drug Administration -- Reports, Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Lung diseases -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-March 22, 2023-: Interstitial Lung Disease Pipeline Assets Segmented by Stage, Product Type, Route of Administration and Molecule Type (C)1994-2023 M2 COMMUNICATIONS RDATE:21032023 DelveInsight's, 'Interstitial Lung Diseases Pipeline Insight, [...]

Published
2023

15. Idiopathic Pulmonary Fibrosis Pipeline Appears Robust with 80+ Key Pharma Companies Actively Working in the Space

Subjects
Pulmonary fibrosis -- Reports -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-January 26, 2023-: Idiopathic Pulmonary Fibrosis Pipeline Appears Robust with 80+ Key Pharma Companies Actively Working in the Space (C)1994-2023 M2 COMMUNICATIONS RDATE:25012023 DelveInsight's, 'Idiopathic Pulmonary Fibrosis Pipeline Insight, [...]

Published
2023

16. Idiopathic Pulmonary Fibrosis Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - FibroGen, Hoffmann-La Roche Ltd., United Therapeutics

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Nitto Denko Corp. -- Forecasts and trends, Business -- Research, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Pulmonary fibrosis -- Reports -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-January 19, 2023-: Idiopathic Pulmonary Fibrosis Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - FibroGen, Hoffmann-La Roche Ltd., United [...]

Published
2023

17. Interstitial Lung Disease Pipeline Insight Report | 120+ Companies and 120+ Drugs

Subjects
United States. Food and Drug Administration -- Reports, Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, Drugs -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-January 17, 2023-: Interstitial Lung Disease Pipeline Insight Report | 120+ Companies and 120+ Drugs (C)1994-2023 M2 COMMUNICATIONS RDATE:16012023 DelveInsight's, 'Interstitial Lung Diseases Pipeline Insight 2023' report provides comprehensive [...]

Published
2023

18. Pulmonary Arterial Hypertension Market to Witness Strong Growth Owing to the Participation of Key Players Such as Acceleron Pharma Inc., United Therapeutics, Altavant Sciences, Aerovate Therapeutics, and Others | DelveInsight

Subjects
United Therapeutics Corp. -- Forecasts and trends, Acceleron Pharma Inc. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Business -- Research, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Biotechnology industry -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The expected launch of drugs by the leading players such as Acceleron Pharma Inc., United Therapeutics, Altavant Sciences, Aerovate Therapeutics, Respira Therapeutics, and others in the pipeline shall fuel the [...]

Published
2022

19. Progressive Fibrosing Interstitial Lung Disease Market to Register Positive Growth at a CAGR of 7.6% by 2032 | DelveInsight

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim Pharmaceuticals Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Progressive Fibrosing Interstitial Lung Disease Market Insights report includes a comprehensive understanding of current treatment practices, progressive [...]

Published
2022

20. Progressive Fibrosing Interstitial Lung Disease Market to Register Positive Growth at a CAGR of 7.6% by 2032 | DelveInsight

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim Pharmaceuticals Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The progressive fibrosing interstitial lung disease market is anticipated to increase due to factors such as increased awareness of PF-ILD along with the expected launch of emerging therapies during the [...]

Published
2022

21. Systemic Sclerosis Market is Projected to Boost at a Moderate Growth Rate by 2032 - DelveInsight | Key Companies - Gesynta Pharma AB, Active Biotech AB, Maruho Co., Ltd., United Therapeutics

Subjects
Systemic scleroderma, Business -- Research, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Biotechnology -- Reports -- Forecasts and trends -- Growth, Scleroderma (Disease), Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 1, 2022-: Systemic Sclerosis Market is Projected to Boost at a Moderate Growth Rate by 2032 - DelveInsight | Key Companies - Gesynta Pharma AB, Active Biotech AB, [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results